- Home
- Primary Care
- Fingolimod as an Effective Oral Escalation Therapy for RRMS Patients With Suboptimal Injectable DMT Adherence
1mo4 min read
Medical Article
Introduction: Relapsing-remitting multiple sclerosis (RRMS) is a chronic demyelinating disease marked by episodes of neurological dysfunction followed by periods of remission (1). Long-term disease control requires ongoing adherence to disease-modifying therapies (DMTs), yet many patients struggle with injectable options due to injection site pain,

Fingolimod as an Effective Oral Escalation Therapy for RRMS Patients With Suboptimal Injectable DMT Adherence
247 Reached
Similar Content

ACC, AHA and ESC Recommendations for Heart Failure Management
2323 Reached29 Comments2 Likes

Catheter Ablation for Atrial Fibrillation with HF
691 Reached

Male Complaining of Bilateral Knee Pain and Gait Disturbance
840 Reached5 Comments1 Likes

Young Girl Presented with Irritability and Abnormal Behavior
2254 Reached10 Comments4 Likes

FOURIER Trial: Efficacy of Evolocumab in Managing Cardiovascular Events
563 Reached3 Comments
